Several of the largest A- series (Sierra Neuropharma at $21 Million) and B-series (Taligen Therapeutics at $65 Million) investments in the nation during the past 18 months have been in this region.

Successful recent exits in the Rocky Mountain region include:

• Ventana Medical Systems, acquired by Roche for $3.4 billion
• Myogen, acquired by Gilead for $2.5 billion
• Pharmion, acquired by Celgene for $2.9 billion
• Sirna, acquired by Merck for $1.1 billion
• Zevex, acquired by Moog for $83.8 million
• Insmed, acquired by Merck for $130 million

Don’t miss this chance to participate in some of the newest deals and meet those who are shaping the future landscape of the life sciences industry.

Registration is now open!